share_log

NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN

NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN

NUTEX HEALTH在威斯康星州開設了第二家醫院,位於密爾沃基急救室。
PR Newswire ·  11/18 18:30

NUTEX HEALTH CONTINUES TO EXPAND ITS NATIONAL FOOTPRINT WITH ITS THIRD HOSPITAL OPENING IN 2024

Nutex Health繼續擴大其全國足跡,預計在2024年開設第三家醫院。

HOUSTON, Nov. 18, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 23 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in ten states and primary care-centric, risk-bearing physician networks, today announced the opening of Milwaukee ER & Hospital, located at 1751 W Layton Ave, Milwaukee, WI 53221.

休斯頓,2024年11月18日 /PRNewswire/ -- Nutex Health Inc.("Nutex Health"或"公司")(納斯達克:NUTX),是一家以醫生爲主導的綜合醫療服務系統,在十個州設有23家先進的微型醫院和醫院門診部(HOPD),並擁有以初級醫療爲中心、具有風險承擔能力的醫生網絡,今天宣佈在威斯康星州密爾沃基市開設密爾沃基急救中心暨醫院,地址爲密爾沃基州萊頓大道西1751號,郵政編碼53221。

The staff of medical experts at Milwaukee ER & Hospital are bringing the community 24/7/365 days of concierge-level care. The 20,000 square foot state-of-the-art facility houses 8 emergency room beds, 6 inpatient beds, one procedure room, an in-house pharmacy, laboratory services, and imaging, including MRI, CT scan, X-ray, and Ultrasound.

密爾沃基急救中心暨醫院的醫療專家團隊爲社區提供24/7/365天的禮賓級護理。這座20,000平方英尺的先進設施設有8張急診室病牀、6張住院病牀、一個手術室、一個內部藥房、實驗室服務以及影像學檢查,包括MRI、CT掃描、X光和超聲波檢查。

"Our expert team of emergency physicians looks forward to showing each patient individualized, excellent care," stated Michaela Wood, M.D., Chief Medical Officer at Milwaukee ER & Hospital.

「我們的急救醫生專家團隊期待爲每位患者提供個性化、優質的護理,」密爾沃基急救中心暨醫院首席醫療官Michaela Wood萬.D.表示。

Patients will be met with the convenience of emergency care in the comfort of a relaxing environment, a short wait, and ample one-on-one time with a board-certified physician. No matter the injury or illness a patient presents, Milwaukee ER & Hospital is equipped to treat patients efficiently and effectively.

患者將享受到在舒適環境中接受急救護理的便利,等待時間短,並能與經過認證的醫生進行充分的一對一交流。無論患者呈現何種傷病,密爾沃基急救中心暨醫院都能夠高效、有效地治療患者。

Following the opening of Green Bay ER & Hospital in Green Bay, Wisconsin and Post Falls ER & Hospital in Post Falls, Idaho, this is the Company's third opening of 2024,

在威斯康星州格林貝市開設格林貝急救中心暨醫院和在愛達荷州波士頓市開設波士頓急救中心暨醫院後,這是公司在2024年的第三次開設。

"We are excited to provide concierge level medical care to the south Milwaukee market, which historically has been underserved," stated Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health.

「我們很高興能爲歷史上服務不足的南密爾沃基市場提供禮賓級醫療服務,」Nutex Health董事長兼首席執行官Tom Vo萬.D.表示。

About Nutex Health Inc.

關於Nutex Health公司

Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.

Nutex Health公司成立於2011年,總部位於德克薩斯州休斯頓,是一家擁有醫院部門和人群健康管理部門的醫療管理和運營公司。

The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 22 facilities in ten states.

醫院部門擁有、開發並運營創新的醫療保健模式,包括微型醫院、專科醫院和醫院門診部(HOPDs)。該部門在十個州擁有並運營22家設施。

The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups.

人口健康管理部門擁有並運營提供者網絡,如獨立醫師協會(IPAs)。通過我們的管理服務組織(MSO),我們爲附屬醫院和醫生團體提供管理、行政和其他支援服務。

Forward-Looking Statements

前瞻性聲明

Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2023 and in the Quarterly Reports on Form 10-Q for the periods ending June 30, 2024 and September 31, 2024 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

本新聞稿中包含的某些聲明和信息構成1995年《私人證券訴訟法》所指的「前瞻性聲明」。在本新聞稿中使用的「將」、「可能會導致」、「預計」、「將繼續」、「預期」、「估計」、「預計」、「打算」、「目標」或類似表達旨在識別1995年《私人證券訴訟改革法》內的「前瞻性聲明」。這些聲明受到某些已知和未知的風險和不確定性的影響,其中許多超出了公司的控制範圍。這些不確定性和風險包括但不限於:我們成功執行增長策略的能力、法律或法規的變更,包括《無驚訝法》下實施的臨時最終規則和最終規則、經濟狀況、對管理的依賴、對股東的稀釋、缺乏資本、快速增長對公司的影響及管理層有效應對公司產品和服務的增長和需求的能力、新興技術、公司的競爭能力、關聯交易中的利益衝突、監管事務、技術保護、缺乏行業標準、競爭的影響以及公司獲得未來融資的能力。影響未來業績的各種因素在截至2023年12月31日的年度報告10-K以及截至2024年6月30日和2024年9月30日的季度報告10-Q中,按照「風險因素」標題進行了詳細討論,包含在第I部分,IA項中,以及其他不時提交給證券交易委員會的文件中。這些因素可能會對公司的財務表現產生重大不利影響,並可能導致公司未來期間的實際結果與本新聞稿中表達的任何意見或陳述有重大差異。

SOURCE Nutex Health, Inc.

SOURCE Nutex Health, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎?

440k+
440k+

Newsrooms &
新聞發佈室&

Influencers
影響力人士
9k+
9k+

Digital Media
數字媒體

Outlets
Outlets
270k+
270k+

Journalists
記者

Opted In
Opted In
GET STARTED
開始使用
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論